Kite Pharma logo

Kite Pharma

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.

4013 employees · est. 2009 · Santa Monica, United States

VS
Quell Therapeutics logo

Quell Therapeutics

Transformational Therapies, Transforming Lives

149 employees · est. 2019 · London, United Kingdom

Kite Pharma is the older company (2009 vs 2019); Kite Pharma is the larger of the two.

Side-by-Side Comparison

Kite Pharma Quell Therapeutics
Founded
2009 older 2019
Headquarters
Santa Monica, United States London, United Kingdom
Employees
4013 larger 149
Industry
Biotechnology, Health Care, Health and Wellness Not tracked yet
Funding Stage
Acquired Series B
Total Funding
$12.56B $231.00M
Funding Rounds
8 4
Services
Cell Therapy Development, Manufacturing of CAR T-cell Therapies, Clinical Trials and Research, Patient Support and Resources, External Research Programs Development and delivery of Treg Therapy for severe immune and inflammatory diseases
Target Customers
Cancer Patients, Healthcare Providers, Research Institutions, Biopharmaceutical Investors, Oncology Care Centers Patients with severe immune and inflammatory diseases
Taxonomy
Cell Therapy, Cancer Immunotherapy, Hematologic Malignancies, Engineered T Cell Therapy, Autologous Cell Therapy, Immune-Based Targeted Therapies, Tumor Cell Reengineering, Cancer Treatment Innovation, Patient-Specific Treatments, Biopharmaceutical Manufacturing, T Cells Engineering, Oncology Therapeutics, Immune System Stimulation Cell Therapy, Immunology, Biotech, Treg Cell Therapy, Solid Organ Transplantation, Autoimmune Conditions, Cell Engineering, Transplant Immunology, Hepatology, Tumor Immunology, Clinical Cell & Gene Therapy, Immune Tolerance, T-cell, Regulatory Cell Therapy, Immune Therapy
Website
kitepharma.com quell-tx.com
Kite Pharma logo

About Kite Pharma

Kite Pharma, a subsidiary of Gilead Sciences, is a pioneering company in the Biotechnology, Health Care, and Health and Wellness industries, renowned for its commitment to cell therapy as a remedy for cancer. Founded in 2009, Kite has positioned itself as a leader in engineered T cell therapy for he...

Quell Therapeutics logo

About Quell Therapeutics

Quell Therapeutics is an exciting new player in the cell therapy immunology biotech industry, with a strong commitment to transforming patients' lives in solid organ transplantation and auto-immune conditions. Founded in 2019 and headquartered in the United Kingdom, the company's slogan, "Transforma...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Kite Pharma and Quell Therapeutics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Kite Pharma and Quell Therapeutics — by email.

Frequently Asked Questions

Kite Pharma — At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. . Quell Therapeutics — Transformational Therapies, Transforming Lives. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Kite Pharma has raised $12.56B while Quell Therapeutics has raised $231.00M.
Kite Pharma and Quell Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Kite Pharma with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy